FAM
IMMU

Fred Alger Management’s Immunomedics Inc IMMU Stock Holding History

Fred Alger Management’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-87,906
Closed -$3.12M – 536
2020
Q2 		$3.12M Buy
87,906
+37,906
+76% +$1.11M 0.01% 276
2020
Q1 		$674K Buy
50,000
+4,000
+9% +$67.3K ﹤0.01% 344
2019
Q4 		$973K Buy
46,000
+3,000
+7% +$52.9K ﹤0.01% 345
2019
Q3 		$570K Buy
+43,000
New +$632K ﹤0.01% 368
2019
Q1 		– Sell
-172,264
Closed -$2.46M – 580
2018
Q4 		$2.46M Sell
172,264
-22,043
-11% -$438K 0.01% 269
2018
Q3 		$4.05M Sell
194,307
-6,377
-3% -$151K 0.02% 238
2018
Q2 		$4.75M Buy
200,684
+63,135
+46% +$1.27M 0.02% 225
2018
Q1 		$2.01M Buy
137,549
+82,549
+150% +$1.35M 0.01% 294
2017
Q4 		$889K Buy
55,000
+41,000
+293% +$484K ﹤0.01% 344
2017
Q3 		$196K Buy
+14,000
New +$140K ﹤0.01% 380

Other funds holding IMMU

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Fred Alger Management's IMMU Position: Q3 2020 in Review

Fred Alger Management sold out of Immunomedics Inc (IMMU) in Q3 2020, closing a stake of 87,906 shares — an estimated $3.12M sold.

Fred Alger Management first reported a position in IMMU in Q3 2017 and held it in 10 quarters. The position peaked at $4.75M in Q2 2018. 408 funds tracked by Wall St. Rank hold IMMU as of Q3 2020.

  • Fred Alger Management reported no remaining Immunomedics Inc position as of Q3 2020 after selling out during the quarter.
  • Fred Alger Management sold 87,906 Immunomedics Inc shares in Q3 2020, an estimated $3.12M.
  • Fred Alger Management first reported a position in Immunomedics Inc in Q3 2017 and held it in 10 quarters.
  • Fred Alger Management's Immunomedics Inc position peaked at $4.75M in Q2 2018.
  • 408 funds tracked by Wall St. Rank held Immunomedics Inc as of Q3 2020.

Based on Fred Alger Management's 13F filing for Q3 2020, filed 13 Nov 2020.